← Leaderboards
Graig W Hendrix
Johns Hopkins University
$0
Attributed
$0
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 2
By mechanism
M01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Justin C McArthur$21,339,205
- Charles W. Flexner$41,000,447
- Chris Beyrer$53,118,025
- Joseph B. Margolick$86,818,342
- Richard Douglas Moore$80,558,192
Others in their field
Top investigators on “Pharmacokinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$237,100,725
- Constance Ann Benson · University Of California, San Diego$151,891,628
- Richard L Schilsky · University Of Chicago$114,474,127
- Ronald T Mitsuyasu · University Of California Los Angeles$105,970,100
- Wafaa M. El-Sadr · Columbia University Health Sciences$91,574,471
- Myron S Cohen · Family Health International$91,263,426
Research focus
PharmacokineticsAntiviral AgentsClinical ResearchClinical Trial Phase IDrug Screening /EvaluationHuman SubjectHuman Therapy EvaluationDrug Abuse ChemotherapyDrug Administration Rate /DurationDrug InteractionsOpiate AlkaloidHiv InfectionsHuman Immunodeficiency Virus 1Outcomes ResearchAids TherapyAntiaids AgentAidsIntravenous AdministrationMethadoneDrug Abuse
Grant awards (6)
PHASE I/II TRIAL OF IV AMD 3100 IN PATIENTS WITH HIV$0
M01 · FY2002 · RR
METHADONE IN COMBO WITH AMPRENAVIR IN OPIATE ABUSERS$0
M01 · FY2002 · RR
PHASE I/II TRIAL OF IV AMD 3100 IN PATIENTS WITH HIV$0
M01 · FY2001 · RR
METHADONE IN COMBO WITH AMPRENAVIR IN OPIATE ABUSERS$0
M01 · FY2001 · RR
PHASE I/II TRIAL OF IV AMD 3100 IN PATIENTS WITH HIV$0
M01 · FY2000 · RR
METHADONE IN COMBO WITH AMPRENAVIR IN OPIATE ABUSERS$0
M01 · FY2000 · RR